Measurement Based Care in Opioid Treatment Programs

NAEnrolling by invitationINTERVENTIONAL
Enrollment

3,650

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

August 31, 2028

Conditions
Opioid Use Disorder
Interventions
BEHAVIORAL

Measurement-based care

Patients will complete MBC measures with their treatment provider and follow-up surveys conducted at baseline and monthly intervals. Both providers and patients will use the Greenspace Mental Health tools to regularly assess patient-reported symptoms, review results together, and collaboratively design individualized treatment plans. Providers will implement MBC to guide treatment adjustments based on these assessments.

BEHAVIORAL

Measurement As Usual

Patients will participate in Measurement As Usual (MAU) via the existing processes available within treatment sites. Currently, patients are assessed and participate in semi-structured interviews at 6-month increments to assess progress and appropriateness of level of care.

Trial Locations (1)

15213

The University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pittsburgh

OTHER

NCT06965010 - Measurement Based Care in Opioid Treatment Programs | Biotech Hunter | Biotech Hunter